Sorafenib Therapy for Pediatric Acute Myeloid Leukemia with FMS-like Tyrosine Kinase 3-internal Tandem Duplication Mutations: 2 Case Reports

被引：1
|
作者：
Osone, Shinya [1 ]
Imamura, Toshihiko [1 ]
Kanayama, Takuyo [1 ,2 ]
Tsuma, Yusuke [1 ]
Kawashima-Goto, Sachiko [1 ]
Nakatani, Takuya [1 ]
Sugimoto, Atsuya [1 ]
Takai, Akari [1 ]
Miyachi, Mitsuru [1 ]
Tamura, Shinichi [2 ]
Ishida, Hiroyuki [1 ,2 ]
Hosoi, Hajime [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Pediat, Kyoto, Japan
[2] Matsushita Mem Hosp, Dept Pediat, Moriguchi, Osaka, Japan
来源：
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2017年 / 39卷 / 04期
关键词：
acute myeloid leukemia; sorafenib; FLT3-ITD; stem cell transplantation; children; STEM-CELL TRANSPLANTATION; MULTIKINASE INHIBITOR SORAFENIB; COMBINATION; CYTARABINE; RELAPSE; HLA;
D O I：
10.1097/MPH.0000000000000672
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Sorafenib is a promising agent for treating pediatric refractory acute myeloid leukemia (AML) exhibiting FMS-like tyrosine kinase 3-internal tandem duplication (FLT3-ITD); however, its optimal use needs to be established. We report 2 cases of refractory pediatric FLT3-ITD-positive AML treated with sorafenib. Case 1 underwent stem cell transplantation (SCT) without entering remission, despite the use of chemotherapy. This patient relapsed despite receiving post-SCT sorafenib. Chemotherapy combined with sorafenib successfully achieved complete remission in case 2. This patient received post-SCT sorafenib and remains in complete remission. The combination of pre-SCT and post-SCT sorafenib may thus be effective for pediatric refractory FLT3-ITD-positive AML.
引用
收藏
页码：E199 / E202
页数：4
相关论文
共 50 条
  • [21] Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
    R Swords
    C Freeman
    F Giles
    Leukemia, 2012, 26 : 2176 - 2185
  • [22] Fms-like tyrosine kinase 3 positive acute myeloid leukemia
    Isidori, Alessandro
    Visani, Giuseppe
    Ferrara, Felicetto
    CURRENT OPINION IN ONCOLOGY, 2023, 35 (06) : 589 - 593
  • [23] Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia
    Nazha, Aziz
    Cortes, Jorge
    Faderl, Stefan
    Pierce, Sherry
    Daver, Naval
    Kadia, Tapan
    Borthakur, Gautam
    Luthra, Raja
    Kantarjian, Hagop
    Ravandi, Farhad
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2012, 97 (08): : 1242 - 1245
  • [24] Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
    Yi, Hai
    Zeng, Dongfeng
    Shen, Zhaohua
    Liao, Jun
    Wang, Xiaoguo
    Liu, Yao
    Zhang, Xi
    Kong, Peiyan
    ONCOTARGET, 2016, 7 (26) : 40387 - 40397
  • [25] Integrin alphavbeta3 enhances β-catenin signaling in acute myeloid leukemia harboring Fms-like tyrosine kinase-3 internal tandem duplication mutations: implications for microenvironment influence on sorafenib sensitivity
    Hai, H.
    Dongfeng, Z.
    Shen, Z.
    Liao, J.
    Wang, X.
    Liu, Y.
    Zhang, X.
    Kong, P.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S480 - S480
  • [26] INTERNAL TANDEM DUPLICATION OF FMS-LIKE TYROSINE KINASE-3 DETERMINES A SIGNIFICANT PROGNOSTIC FACTOR ON ACUTE PROMYELOCYTIC LEUKEMIA
    Tashiro, H.
    Oka, Y.
    Shirasaki, R.
    Sugao, T.
    Mizutani-Noguchi, M.
    Akiyama, N.
    Kawasugi, K.
    Shirafuji, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 510 - 510
  • [27] FMS-Like Tyrosine Kinase 3 Inhibitors for the Treatment of Acute Myeloid Leukemia
    Novatcheva, Elli D.
    Anouty, Yasmine
    Saunders, Ila
    Mangan, James K.
    Goodman, Aaron M.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (03): : E161 - E184
  • [28] FMS-like tyrosine kinase 3 in normal hematopoiesis and acute myeloid leukemia
    Parcells, Bertrand W.
    Ikeda, Alan K.
    Simms-Waldrip, Tiffany
    Moore, Theodore B.
    Sakamoto, Kathleen M.
    STEM CELLS, 2006, 24 (05) : 1174 - 1184
  • [29] FMS-like Tyrosine Kinase 3-Internal Tandem Duplication Allele Concentrations Should Be Determined in a Mutation-Type-Specific Manner
    Kim, Man Jin
    Shin, Ho Seob
    Oh, Hyeon Sae
    Cho, Sung Im
    Kim, Young-Gon
    Lee, Jee-Soo
    Park, Sung Sup
    Seong, Moon-Woo
    CLINICAL CHEMISTRY, 2021, 67 (04) : 691 - 693
  • [30] Detection of nucleophosmin and FMS-like tyrosine kinase-3 gene mutations in acute myeloid leukemia
    Pazhakh, Vahid
    Zaker, Farhad
    Alimoghaddam, Kamran
    Atashrazm, Farzaneh
    ANNALS OF SAUDI MEDICINE, 2011, 31 (01) : 45 - 50
12345